Dexcom (DC4) Q2 2021 Earnings Report
0 Followers
CH:DC4 Q2 2021 EPS Results
- Actual EPS
- CHF 0.15
- Consensus EPS
- CHF 0.09
- Beat/Miss
- Beat by +CHF 0.06
- One Year Ago EPS
- CHF 0.16
CH:DC4 Q2 2021 Revenue Results
- Actual Revenue
- CHF 485.46M
- Expected Revenue
- CHF 450.03M
- Beat/Miss
- Beat by +CHF 35.43M
- YoY Revenue Growth
- +31.72%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/29/2021
- Time
- After Close
- Conference Call
- Thursday, July 29, 2021
CH:DC4 Upcoming Earnings
Dexcom's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:DC4 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | 0.58- | 0.55 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.550.60 | 0.5 | 19.67% (+0.10) | |
| Jul 30, 2026 | 2026 (Q2) | 0.500.57 | 0.39 | 45.83% (+0.18) | |
| Apr 30, 2026 | 2026 (Q1) | 0.380.46 | 0.26 | 75.00% (+0.20) | |
| Feb 12, 2026 | 2025 (Q4) | 0.530.55 | 0.37 | 51.11% (+0.19) | |
| Oct 30, 2025 | 2025 (Q3) | 0.470.50 | 0.37 | 35.56% (+0.13) | |
| Jul 30, 2025 | 2025 (Q2) | 0.360.39 | 0.35 | 11.63% (+0.04) | |
| May 01, 2025 | 2025 (Q1) | 0.270.26 | 0.26 | 0.00% (+0.00) | |
| Feb 13, 2025 | 2024 (Q4) | 0.390.37 | 0.41 | -10.00% (-0.04) | |
| Oct 24, 2024 | 2024 (Q3) | 0.350.37 | 0.41 | -10.00% (-0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
